Dr. Muhammad Ikram
Biography
Dr. Muhammad Ikram is an Assistant Professor of Pharmacology at the Institute of Pharmaceutical Sciences, Khyber Medical University (IPS-KMU), with a background in neuroscience, neurobiology, and neuropharmacology. He holds a Pharm-D, an MPhil in Biochemistry, and a PhD in Neuroscience (Neurobiology/Neuropharmacology). He has also completed postdoctoral research at Gyeongsang National University, South Korea, and the University of Texas Health Science Center, USA.
His research focuses on understanding the molecular and cellular mechanisms underlying neurodegenerative and metabolic disorders, as well as traumatic and ischemic brain injury. He has extensive in-vitro and in-vivo research experience using experimental models of Alzheimer’s disease, Parkinson’s disease, ischemic stroke, and traumatic brain injury.
Dr. Ikram has published 38 research papers, including 20 as first author and 18 as an equally contributing co-author. He also contributes to the scientific community through editorial and peer-review activities, including roles with Frontiers in Pharmacology, Frontiers in Neuroscience, and several international scientific journals.
Research Interests
Neurodegeneration & Neuroinflammation Neuroprotective Drug Discovery & Brain Injury
Publications
- Emodin, a potent anthraquinone mitigates MPTP-induced parkinsons’ disease pathology by regulating Nrf2 and its downstream targets: in Silico and in vivo approach — Sarwat Jahan, Muhammad Ikram, Sami Siraj, Shakir Ullah, Muhammad Zakria, Nasir Ahmad , Journal (2025)
- Alpha‐Linolenic Acid for Mitigating Neuroinflammation and Dopaminergic Neuronal Loss in Parkinson's Disease: Insights From In Vivo and In Silico Studies — Mahnoor, Sarwat Jahan, Laila Elahi, Muhammad Zakria, Rabia, Muhammad Ikram, Najeeb Ullah , Journal (2025)
- Emerging biomarkers in major depressive disorder: Diagnostic, prognostic, and therapeutic implications — M Kamran Ameer, Muhammad Ikram, M Imran Khan, Fazal Wahab, M Imran Naseer, Najeeb Ullah , Journal (2025)
- Probiotic significance of Lactobacillus strains: a comprehensive review on health impacts, research gaps, and future prospects — Abdul Bari Shah, Aizhamal Baiseitova, Muhammad Zahoor, Ishaq Ahmad, Muhammad Ikram, Allah Bakhsh, Murad Ali Shah, Imdad Ali, Muhammad Idress, Riaz Ullah, Fahd A Nasr, Mohammed Al-Zharani , Journal (2024)
- Systematic review of the common pathophysiological mechanisms in COVID-19 and neurodegeneration: the role of bioactive compounds and natural antioxidants — Kyonghwan Choe, Hyun Young Park, Muhammad Ikram, Hyeon Jin Lee, Tae Ju Park, Rahat Ullah, Myeong Ok Kim , Journal (2022)